Opportunity Information: Apply for CDC RFA PS12 120604CONT15
Apply for CDC RFA PS12 120604CONT15
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Implementing a National Framework to Eliminate Mother to Child HIV Transmission in the United States" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.118 Acquired Immunodeficiency Syndrome (AIDS) Activity.
- This funding opportunity was created on Apr 8, 2015 and posted on Apr 8, 2015.
- Applicants must submit their applications by May 1, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 50 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- This award will be a continuation of funds intended only for grantees previously awarded under PS12 1206 Implementing a National Framework to Eliminate Mother to Child HIV Transmission in the United States
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, titled "Implementing a National Framework to Eliminate Mother to Child HIV Transmission in the United States," is a Centers for Disease Control and Prevention (CDC) cooperative agreement continuation designed to support ongoing work aimed at eliminating perinatal (mother-to-child) HIV transmission nationwide. It is listed under Funding Opportunity Number CDC RFA PS12-120604CONT15 and falls within the health activity category, with the relevant CFDA number 93.118 (Acquired Immunodeficiency Syndrome (AIDS)). The opportunity was posted on April 8, 2015, with an application closing date of May 1, 2015, and an archive date of May 31, 2015. The listing indicates an expected 50 awards.
A key point is that this is not an open competition. The announcement states that it is a continuation of funds and is intended only for recipients previously funded under PS12-1206, which carried the same initiative name. In other words, eligibility is limited to existing grantees already working under the prior award, and the "Eligible Applicants" field is broadly labeled as "Others," with clarification in the eligibility section that only prior PS12-1206 awardees may apply. There is no cost sharing or matching requirement, meaning recipients are not required to contribute non-federal funds as a condition of the award.
Because it is structured as a cooperative agreement rather than a standard grant, the program is set up for substantial involvement by CDC in the funded work. In practical terms, cooperative agreements typically mean recipients carry out programmatic activities while collaborating closely with CDC on planning, implementation, and performance monitoring to ensure the work aligns with national public health priorities and agreed-upon outcomes. Although the provided summary does not include specific required activities or deliverables, the title and program framing indicate that funding supports implementation of a national framework focused on preventing HIV transmission from mother to child, which generally involves strengthening systems that identify HIV in pregnancy, ensuring effective treatment and viral suppression during pregnancy, supporting safe delivery and infant prophylaxis practices, coordinating care for mother-infant pairs, and improving surveillance and follow-up so that transmission events are prevented or rapidly identified and addressed.
The funding fields in the source data list an estimated total funding amount of 0 and award floor/ceiling values of 0, which usually reflects that dollar amounts were not populated in the public-facing record or were handled through continuation award mechanisms rather than posted as new competitive totals. Applicants relying on this listing would typically need to refer to the underlying continuation guidance provided directly to existing recipients or to the original PS12-1206 program documents for more detail on budgets, work plans, and reporting expectations.
For assistance accessing the full announcement materials, the CDC Procurement and Grants Office contact provided is pgotim@cdc.gov.
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The funding opportunity is titled "Implementing a National Framework to Eliminate Mother to Child HIV Transmission in the United States."
Which agency is offering this opportunity?
This opportunity is offered by the Centers for Disease Control and Prevention (CDC).
What type of funding mechanism is this?
This is a cooperative agreement continuation. A cooperative agreement generally involves substantial CDC involvement in the funded work, meaning recipients typically collaborate closely with CDC on planning, implementation, and performance monitoring.
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA PS12-120604CONT15.
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.118, Acquired Immunodeficiency Syndrome (AIDS).
Is this an open competitive funding opportunity?
No. The announcement states this is not an open competition. It is a continuation of funds intended only for recipients previously funded under PS12-1206 (the prior award carrying the same initiative name).
Who is eligible to apply?
Eligibility is limited to existing grantees previously funded under PS12-1206. Although the "Eligible Applicants" field is labeled as "Others," the eligibility section clarifies that only prior PS12-1206 awardees may apply.
If our organization was not funded under PS12-1206, can we apply?
Based on the information provided, no. This continuation is intended only for recipients previously funded under PS12-1206.
When was the opportunity posted?
The opportunity was posted on April 8, 2015.
What is the application closing date?
The application closing date is May 1, 2015.
When was the opportunity archived?
The archive date is May 31, 2015.
How many awards are expected?
The listing indicates an expected 50 awards.
What is the activity category for this opportunity?
The opportunity falls within the health activity category.
Is cost sharing or matching required?
No. The listing states there is no cost sharing or matching requirement, meaning recipients are not required to contribute non-federal funds as a condition of the award.
What does CDC "substantial involvement" mean in this cooperative agreement?
While the summary does not list specific required activities or deliverables, the cooperative agreement structure typically means recipients implement program activities while working closely with CDC on planning, implementation, and performance monitoring to ensure alignment with national public health priorities and agreed-upon outcomes.
What is the overall purpose of the funded work?
The purpose is to support ongoing work aimed at eliminating perinatal (mother-to-child) HIV transmission nationwide by implementing a national framework focused on preventing HIV transmission from mother to child.
Are specific activities or deliverables described in the provided summary?
No. The provided summary does not include specific required activities or deliverables.
What kinds of activities does this initiative generally support, based on the framing and title?
Based on the title and program framing, the work generally relates to preventing mother-to-child HIV transmission, which typically involves strengthening systems to identify HIV in pregnancy, ensuring effective treatment and viral suppression during pregnancy, supporting safe delivery and infant prophylaxis practices, coordinating care for mother-infant pairs, and improving surveillance and follow-up so transmission events are prevented or rapidly identified and addressed.
Why do the funding amount fields show zeros?
The funding fields list an estimated total funding amount of 0 and award floor/ceiling values of 0. This usually indicates dollar amounts were not populated in the public-facing record or were handled through continuation award mechanisms rather than posted as new competitive totals.
Where should existing recipients look for budget, work plan, and reporting details?
The listing indicates applicants would typically need to refer to the underlying continuation guidance provided directly to existing recipients or to the original PS12-1206 program documents for more detail on budgets, work plans, and reporting expectations.
Who can be contacted for help accessing the full announcement materials?
For assistance accessing the full announcement materials, the CDC Procurement and Grants Office contact provided is pgotim@cdc.gov.
Does the listing indicate any award floor or ceiling amounts?
The listing shows award floor and ceiling values of 0, which generally suggests the amounts were not populated in the public record for this continuation.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Office of Innovation and Improvement Development grants Pre Application CFDA Number 84.411P
Previous opportunity: FY 2015 Global Sports Mentoring Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS12 120604CONT15
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS12 120604CONT15) also looked into and applied for these:
| Funding Opportunity |
|---|
| Domestic Laboratory Biosafety for Ebola and other Highly Infectious Diseases Apply for CDC RFA OE15 1504 Funding Number: CDC RFA OE15 1504 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Health Department Demonstration Projects for Comprehensive Prevention, Care, Behavioral Health, and Social Services for Men Who Have Sex with Men of Color at Risk for and Living with HIV Infection Apply for CDC RFA PS15 1509 Funding Number: CDC RFA PS15 1509 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,333,333 |
| NIAMS Clinical Trial Planning Cooperative Agreement (U34) Apply for PAR 15 166 Funding Number: PAR 15 166 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Preventive Medicine Residency with Integrative Health Care Training Program Apply for HRSA 15 143 Funding Number: HRSA 15 143 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons Apply for CDC RFA PS15 1506 Funding Number: CDC RFA PS15 1506 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $7,000,000 |
| Training and Technical Assistance for Health Department Demonstration Projects for Comprehensive Prevention, Care, Behavioral Health, and Social Services for Men Who Have Sex with Men of Color At Risk for and Living with HIV Infection Apply for CDC RFA PS15 1510 Funding Number: CDC RFA PS15 1510 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Request for Information for RFI 674 15 RHAP 001 Apply for RFI 674 15 RHAP 001 Funding Number: RFI 674 15 RHAP 001 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| HIV Vaccine Research and Design (HIVRAD) Program (P01) Apply for PAR 15 164 Funding Number: PAR 15 164 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Training and Technical Assistance Cooperative Agreements (NCAs) Apply for HRSA 15 140 Funding Number: HRSA 15 140 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIAMS Clinical Trial Implementation Cooperative Agreement (U01) Apply for PAR 15 165 Funding Number: PAR 15 165 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tuberculosis Health Action Learning Initiative (THALI) Apply for RFA 386 15 000001 Funding Number: RFA 386 15 000001 Agency: India USAID New Delhi Category: Health Funding Amount: $9,500,000 |
| NIBIB Research Education Programs for Residents and Clinical Fellows (R25) Apply for PAR 15 167 Funding Number: PAR 15 167 Agency: National Institutes of Health Category: Health Funding Amount: $70,000 |
| PPHF 2015 Cooperative Agreements for State Sponsored Youth Suicide Prevention and Early Intervention (PPHF 2015) Apply for SM 15 004 Funding Number: SM 15 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $736,000 |
| Alzheimers Drug Development Program (U01) Apply for PAR 15 174 Funding Number: PAR 15 174 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| PPHF 2015 Empowering Older Adults and Adults with Disabilities through Chronic Disease Self Management Education Programs Financed Solely by 2015 Prevention and Public Health Funds (PPHF 2015) Apply for HHS 2015 ACL AOA CS 0094 Funding Number: HHS 2015 ACL AOA CS 0094 Agency: Administration for Community Living Category: Health Funding Amount: $900,000 |
| Epicenters for the Prevention of Healthcare Associated Infections (HAI) Cycle II Apply for RFA CK 15 004 Funding Number: RFA CK 15 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,200,000 |
| Native Hawaiian Health Care Improvement Act Apply for HRSA 15 017 Funding Number: HRSA 15 017 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01) Apply for PAR 15 172 Funding Number: PAR 15 172 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Oral Immune System Plasticity in Chronic HIV Infection Under Treatment and Oral Co Infections (R01) Apply for RFA DE 16 002 Funding Number: RFA DE 16 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pre Application for Collaborative Innovation Award, CTSA Program (X02) Apply for PAR 15 173 Funding Number: PAR 15 173 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS12 120604CONT15", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.